...
首页> 外文期刊>Journal of International Medical Research >Haploidentical Allogeneic Haematopoietic Stem Cell Transplantation as Salvage Therapy for Engraftment Failure after Unrelated and Autologous Stem Cell Transplantation: A Case Report and Review of the Literature
【24h】

Haploidentical Allogeneic Haematopoietic Stem Cell Transplantation as Salvage Therapy for Engraftment Failure after Unrelated and Autologous Stem Cell Transplantation: A Case Report and Review of the Literature

机译:单倍体同种异体造血干细胞移植作为不相关和自体干细胞移植后植入失败的挽救疗法:一例病例并文献复习

获取原文
           

摘要

Engraftment failure is a rare but life-threatening complication of haematopoietic stem cell transplantation (HSCT) and treatment of this condition is often challenging. This case report describes a patient with acute myeloid leukaemia and engraftment failure after unrelated donor allogeneic stem cell transplantation. Rescue treatment with granulocyte-colony stimulating factor and reinfusion of autologous ‘back-up’ stem cells failed, but transplantation of haploidentical donor stem cells following a fludarabine and antithymocyte globulin (ATG)-based conditioning regimen resulted in haematological reconstitution and long-term disease-free survival. The use of haploidentical donor stem cell transplantation as salvage therapy after engraftment failure in adult patients has not, to the authors' knowledge, been previously reported. Additionally, a review of the relevant literature is presented. This case report and literature review suggest that reinfusion of cryopreserved ‘back-up’ haematopoietic stem cells is a safe and effective salvage therapy for engraftment failure after allogeneic HSCT. Haploidentical donor stem cell transplantation after a fludarabine and ATG-based conditioning regimen could provide effective second-line therapy in adult patients.
机译:植入失败是造血干细胞移植(HSCT)的罕见但危及生命的并发症,治疗该病症通常具有挑战性。该病例报告描述了不相关供体同种异体干细胞移植后患有急性髓细胞性白血病和移植失败的患者。用粒细胞集落刺激因子进行的抢救治疗和自体“后备”干细胞的再输注均失败,但是在基于氟达拉滨和抗胸腺细胞球蛋白(ATG)的调理方案下,单倍体供体干细胞的移植导致血液学重建和长期疾病生存。据作者所知,以前没有报道过在成年患者植入失败后使用单倍体供体干细胞移植作为挽救疗法。此外,还介绍了相关文献。该病例报告和文献综述表明,冷冻保存的“备用”造血干细胞回输是异基因HSCT后植入失败的一种安全有效的挽救疗法。氟达拉滨和基于ATG的调节方案后的单倍体供体干细胞移植可以为成年患者提供有效的二线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号